Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACN Accenture	$247.04 +0.4%	$285.33	$236.67 ▼ $398.35	$154.73B	1.29	3.55 million shs	4.22 million shs
GLOB Globant	$66.54 -14.8%	$88.27	$64.51 ▼ $238.32	$2.93B	1.16	1.15 million shs	7.48 million shs
ICLR Icon	$175.84 +0.3%	$155.41	$125.10 ▼ $328.35	$14.20B	1.17	1.32 million shs	892,297 shs
RTO Rentokil Initial	$24.51 -2.5%	$23.94	$19.60 ▼ $34.07	$12.38B	0.92	801,994 shs	494,231 shs

Analysts Agree—These Gold Picks Outshine the Rest

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACN Accenture	+0.19%	+1.76%	-10.91%	-22.49%	-23.06%
GLOB Globant	-1.83%	+0.25%	-5.49%	-22.45%	-59.15%
ICLR Icon	-0.53%	+11.09%	+20.46%	+33.22%	-44.75%
RTO Rentokil Initial	-0.82%	+0.40%	+10.32%	+7.54%	-18.26%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ACN Accenture	4.9887 of 5 stars	4.3	3.0	4.2	3.1	3.5	2.5	2.5
GLOB Globant	4.9053 of 5 stars	4.3	2.0	0.0	3.6	3.9	1.7	3.1
ICLR Icon	4.7518 of 5 stars	4.4	5.0	0.0	0.0	3.3	3.3	2.5
RTO Rentokil Initial	1.5711 of 5 stars	0.0	3.0	2.5	0.0	3.5	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACN Accenture	2.67	Moderate Buy	$360.21	44.97% Upside
GLOB Globant	2.56	Moderate Buy	$153.56	135.22% Upside
ICLR Icon	2.81	Moderate Buy	$219.54	24.12% Upside
RTO Rentokil Initial	2.50	Moderate Buy	N/A	N/A

Current Analyst Ratings Breakdown

Latest GLOB, ACN, ICLR, and RTO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/15/2025	GLOB Globant	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$115.00 ➝ $85.00
8/15/2025	GLOB Globant	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$78.00
7/28/2025	ACN Accenture	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Reduce	$240.00
7/28/2025	ACN Accenture	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Moderate Sell
7/25/2025	ICLR Icon	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$173.00 ➝ $225.00
7/25/2025	ICLR Icon	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$187.00 ➝ $234.00
7/25/2025	ICLR Icon	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$170.00 ➝ $240.00
7/25/2025	ICLR Icon	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$155.00 ➝ $180.00
7/25/2025	ICLR Icon	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$170.00 ➝ $240.00
7/24/2025	ICLR Icon	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/24/2025	ICLR Icon	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$150.00 ➝ $224.00

(Data available from 8/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACN Accenture	$64.90B	2.40	$15.76 per share	15.77	$46.54 per share	5.34
GLOB Globant	$2.42B	1.19	$7.28 per share	8.97	$47.19 per share	1.38
ICLR Icon	$8.28B	1.72	$20.10 per share	8.80	$118.32 per share	1.49
RTO Rentokil Initial	$6.95B	1.80	$2.51 per share	9.85	$10.70 per share	2.31

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACN Accenture	$7.26B	$12.56	19.77	18.10	2.24	11.61%	26.55%	13.44%	9/25/2025 (Estimated)
GLOB Globant	$165.73M	$3.38	19.25	9.09	3.27	6.16%	11.08%	7.38%	N/A
ICLR Icon	$791.47M	$9.72	18.21	11.57	2.38	9.82%	10.95%	6.23%	10/22/2025 (Estimated)
RTO Rentokil Initial	$392.32M	$1.51	16.34	17.51	4.35	N/A	N/A	N/A	N/A

Latest GLOB, ACN, ICLR, and RTO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	GLOB Globant	$1.52	$1.53	+$0.01	-$0.05	$612.66 million	$614.18 million
7/23/2025	Q2 2025	ICLR Icon	$3.18	$3.26	+$0.08	$2.30	$1.98 billion	$2.02 billion
6/20/2025	Q3 2025	ACN Accenture	$3.32	$3.49	+$0.17	$3.49	$17.26 billion	$17.73 billion
5/15/2025	Q1 2025	GLOB Globant	$1.58	$1.50	-$0.08	$0.68	$622.18 million	$611.09 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACN Accenture	$5.92	2.38%	N/A	47.13%	20 Years
GLOB Globant	N/A	N/A	N/A	N/A	N/A
ICLR Icon	N/A	N/A	N/A	N/A	N/A
RTO Rentokil Initial	$0.69	2.79%	N/A	45.70%	N/A

Latest GLOB, ACN, ICLR, and RTO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/4/2025	RTO Rentokil Initial	semi-annual	$0.2738	2.4%	8/15/2025	8/15/2025	9/23/2025
6/20/2025	ACN Accenture	quarterly	$1.48	1.93%	7/10/2025	7/10/2025	8/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACN Accenture	0.16	1.46	1.46
GLOB Globant	0.13	1.56	1.56
ICLR Icon	0.35	1.29	1.29
RTO Rentokil Initial	0.59	0.81	0.72

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ACN Accenture	75.14%
GLOB Globant	91.60%
ICLR Icon	95.61%
RTO Rentokil Initial	9.91%

Insider Ownership

Company	Insider Ownership
ACN Accenture	0.02%
GLOB Globant	2.67%
ICLR Icon	44.00%
RTO Rentokil Initial	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ACN Accenture	774,000	626.33 million	626.20 million	Optionable
GLOB Globant	31,280	44.03 million	42.85 million	Optionable
ICLR Icon	41,900	80.76 million	45.22 million	Optionable
RTO Rentokil Initial	68,485	505.21 million	N/A	Not Optionable

GLOB, ACN, ICLR, and RTO Headlines

Recent News About These Companies

Motley Fool Asset Management LLC Cuts Stock Position in Rentokil Initial PLC (NYSE:RTO)

August 13 at 5:25 AM | marketbeat.com

Townsquare Capital LLC Grows Stake in Rentokil Initial PLC (NYSE:RTO)

August 13 at 4:25 AM | marketbeat.com

Motley Fool Wealth Management LLC Purchases 16,288 Shares of Rentokil Initial PLC (NYSE:RTO)

August 12 at 6:48 AM | marketbeat.com

Koss Olinger Consulting LLC Buys 55,896 Shares of Rentokil Initial PLC (NYSE:RTO)

August 10, 2025 | marketbeat.com

Rentokil Initial rallies Thursday, outperforms market

August 7, 2025 | marketwatch.com

52,432 Shares in Rentokil Initial PLC (NYSE:RTO) Purchased by ABC Arbitrage SA

August 7, 2025 | marketbeat.com

Rentokil Initial climbs Wednesday, outperforms market

August 6, 2025 | marketwatch.com

Rentokil Initial PLC (NYSE:RTO) to Issue Semi-annual Dividend of $0.27

August 5, 2025 | marketbeat.com

Battle of the Bugs: Which Pest Control Stock is Best?

August 5, 2025 | msn.com

Bank of New York Mellon Corp Cuts Position in Rentokil Initial PLC (NYSE:RTO)

August 3, 2025 | marketbeat.com

Alberta Investment Management Corp Boosts Stock Holdings in Rentokil Initial PLC (NYSE:RTO)

August 2, 2025 | marketbeat.com

Rentokil Initial PLC (RKLIF) (Q2 2025) Earnings Call Highlights: Revenue Growth and Strategic ...

August 1, 2025 | gurufocus.com

Half Year 2025 Rentokil Initial PLC Earnings Call Transcript

August 1, 2025 | gurufocus.com

Rentokil Initial (NYSE:RTO) Shares Gap Up - Still a Buy?

August 1, 2025 | marketbeat.com

Rentokil shares jump as US turnaround lifts outlook

July 31, 2025 | proactiveinvestors.co.uk

First Foundation Advisors Invests $339,000 in Rentokil Initial PLC (NYSE:RTO)

July 31, 2025 | marketbeat.com

Assetmark Inc. Has $1.89 Million Stake in Rentokil Initial PLC (NYSE:RTO)

July 31, 2025 | marketbeat.com

Rentokil jumps as US business shows first improvements

July 31, 2025 | proactiveinvestors.co.uk

W.G. Shaheen & Associates DBA Whitney & Co Grows Stock Holdings in Rentokil Initial PLC (NYSE:RTO)

July 23, 2025 | marketbeat.com

Rentokil should enjoy improving organic trends in North America pest control business - broker

July 21, 2025 | proactiveinvestors.co.uk

Envestnet Asset Management Inc. Has $17.82 Million Stock Position in Rentokil Initial PLC (NYSE:RTO)

July 18, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

GLOB, ACN, ICLR, and RTO Company Descriptions

Accenture NYSE:ACN

$247.04 +0.88 (+0.36%)

Closing price 03:59 PM Eastern

Extended Trading

$247.00 -0.04 (-0.02%)

As of 06:33 PM Eastern

Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services. It also provides change management, HR transformation and delivery, organization strategy and design, talent strategy and development, and leadership and culture services; digital commerce; infrastructure services, including cloud infrastructure managed, cloud and data center, network, digital workplace, database platforms, service management, and cloud and infrastructure security services; data-enabled operating models; technology consulting and AI services; and technology consulting services. In addition, the company offers engineering and R&D digitization, smart connected products, product as-a-service enablement, capital projects, intelligent asset management, digital industrial workforce, and autonomous robotic systems; business process outsourcing; and services related to technology innovation. Further, it provides cloud, ecosystem, marketing, security, supply chain management, zero-based transformation, customer experience, finance consulting, mergers and acquisitions, and sustainability services. The company has a collaboration with Salesforce, Inc. to develop Salesforce Life Sciences Cloud. The company was founded in 1951 and is based in Dublin, Ireland.

Globant NYSE:GLOB

$66.54 -11.58 (-14.82%)

Closing price 03:58 PM Eastern

Extended Trading

$66.30 -0.24 (-0.36%)

As of 06:34 PM Eastern

Globant S.A., together with its subsidiaries, provides technology services worldwide. It provides digital solutions comprising blockchain, cloud technologies, cybersecurity, data and artificial intelligence, digital experience and performance, code, Internet of Things, metaverse, and engineering and testing; and enterprise technology solutions and services, such as Agile organization, Cultural Hacking, process optimization services, as well as AWS, Google Cloud, Microsoft, Oracle, SalesForce, SAP, and ServiceNow technology solutions. Further, the company provides e-commerce, conversational interfaces, design, digital marketing, and digital product delivery services. Additionally, it operates Augoor, an AI-powered platform; MagnifAI, an AI-powered solution for software quality assurance; StarMeUp, a science-based AI platform; WaaSabi, a finance platform; Walmeric, a lead-to-revenue management platform; GeneXus, a suit of AI development tools; Navigate for process optimization powerhouse; BeHealthy, a white-label platform; and FluentLab, an AI conversational and engagement solution. The company offers its services to various industries, including media and entertainment, professional services, technology and telecommunications, travel and hospitality, banks, financial services and insurance, consumer, retail and manufacturing, health care, and others. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.

Icon NASDAQ:ICLR

$175.84 +0.48 (+0.27%)

Closing price 04:00 PM Eastern

Extended Trading

$175.87 +0.03 (+0.02%)

As of 04:20 PM Eastern

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Rentokil Initial NYSE:RTO

$24.51 -0.63 (-2.51%)

Closing price 03:59 PM Eastern

Extended Trading

$24.08 -0.43 (-1.75%)

As of 05:54 PM Eastern

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers. The company provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats. In addition, it engages in the supply and maintenance of workwear and protective equipment. Further, the company offers property care services; and provides a range of specialist cleaning services, such as graffiti removal deep cleaning of kitchens and washrooms, trauma cleaning, and flood or fire damage cleaning, as well as specialist medical and hygiene services. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time